About My Health Careers Internship MedBlogs Contact us
Medindia LOGIN REGISTER
Advertisement

New and Better Way to Treat Depression

by Anjali Aryamvally on March 2, 2018 at 2:48 PM
Font : A-A+

New and Better Way to Treat Depression

A new target for treating major depressive disorder has been discovered by a research team at the Florida campus of The Scripps Research Institute (TSRI). Individuals with high levels of an enigmatic receptor called GPR158 may be more susceptible to depression following chronic stress, shows study.

"The next step in this process is to come up with a drug that can target this receptor," says Kirill Martemyanov, PhD, co-chair of the TSRI Department of Neuroscience and senior author of the new study, published in the journal eLife.

Advertisement


The researchers say there is an urgent need for new drug targets in major depressive disorder. Current pharmacological treatments for depression can take a month to start working--and they don't work in all patients.

"We need to know what is happening in the brain so that we can develop more efficient therapies," says Cesare Orlandi, PhD, senior research associate at TSRI and co-first author of the study.
Advertisement

The researchers zeroed in on GPR158 as a player in depression after discovering that the protein is elevated in people with major depressive disorder. To better understand GPR158's role, the scientists studied male and female mice with and without GPR158 receptors.

Behavioral tests revealed that both male and female mice with elevated GPR158 show signs of depression following chronic stress. On the flip side, suppression of GPR158 protects mice from developing depressive-like behaviors and make them resilient to stress.

Next, the researchers examined why GPR158 has these effects on depression. The team demonstrated that GPR158 affects key signaling pathways involved in mood regulation in the region of the brain called prefrontal cortex, though the researchers emphasized that the exact mechanisms remain to be established.

Martemyanov explains that GPR158 is a so-called "orphan receptor" (which gets its name because its binding partner/partners are unknown) with a poorly understood biology and mechanism of action. GPR158 appears to work downstream from other important brain systems, such as the GABA, a major player in the brain's inhibitory control and adrenergic system involved in stress effects.

"This is really new biology and we still need to learn a lot," says Martemyanov.

The study also offers a potential clue to why some people are more susceptible to mental illness. Because mice without GPR158 don't alter their behavior after chronic stress, the researchers concluded these mice were naturally more resilient against depression. Their genetics, or gene expression, offer a layer of protection.

Laurie Sutton, PhD, a research associate at TSRI and co-first author of the study, says this finding matches what doctors have noticed in people who have experienced chronic stress. "There's always a small population that is resilient--they don't show the depressive phenotype," says Sutton.

As the search goes on for additional targets for depression, Martemyanov says scientists are increasingly using new tools in genome analysis to identify orphan receptors like GPR158.

"Those are the untapped biology of our genomes, with significant potential for development of innovative therapeutics," he says.



Source: Eurekalert
Advertisement

Advertisement
News A-Z
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Advertisement
News Category
What's New on Medindia
Black Pepper as Preventive Measure Against Omicron
FODMAP Diet: A Beginner's Guide
Smallpox
View all

Medindia Newsletters Subscribe to our Free Newsletters!
Terms & Conditions and Privacy Policy.

More News on:
Adolescence Depression Depression Stress Relief Through Alternative Medicine Andropause / Male Menopause Pregnancy and Complications Holistic Management for Depression Tourette Syndrome Dealing with Menopause symptoms through lifestyle changes Tired All The Time Placebo Effects: Rare Insights 

Recommended Reading
Untreated Depression Over the Years Can Cause Inflammation in the Brain
Depression is not considered a degenerative brain disease but the change in inflammation shows that ...
CASA Alleviates Depression and Fatigue in Patients With Heart Failure
CASA intervention in patients with chronic heart failure alleviated depression and fatigue ......
Hormonal Birth Control Does Not Increase Depression Risk in Women
Hormonal birth control doesn't cause depression in women. Pregnant moms will sometimes have a ......
Reduced Arginine Bioavailability Due to Depression
Arginine level in the body is reduced for people suffering with major depressive disorder(MDD). ......
Andropause / Male Menopause
Andropause or male menopause causing low libido in a man is due to decreasing level of male hormones...
Dealing with Menopause symptoms through lifestyle changes
You can deal with menopause symptoms such as hot flashes, weight gain and forgetfulness by making si...
Depression
Depression is one of the most common mental disorders affecting approximately 340 million people in ...
Holistic Management for Depression
Depression is a common disorder and many worldwide suffer from depression. Early recognition of symp...
Placebo Effects: Rare Insights
Placebo response is now generally well accepted. ‘Placebo response’ is the friend of the clinician a...
Pregnancy and Complications
In-depth guide for expecting mothers to overcome health complications related to early or late pregn...
Tired All The Time
Tired All The Time (TATT) syndrome is not only about feeling of tired, however there are a host of o...
Tourette Syndrome
Tourette syndrome (TS) is a neurological disorder wherein the affected person makes repetitive and s...

Disclaimer - All information and content on this site are for information and educational purposes only. The information should not be used for either diagnosis or treatment or both for any health related problem or disease. Always seek the advice of a qualified physician for medical diagnosis and treatment. Full Disclaimer

© All Rights Reserved 1997 - 2022

This site uses cookies to deliver our services. By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use